NY-ESO-1 TCR （TAEST16001）for Patients With Advanced NSCLC

Clinical trial NCT03029273 · UNKNOWN

Trial details

NCT number: NCT03029273
Sponsor: Guangzhou Institute of Respiratory Disease
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Lung Cancer, Nonsmall Cell, Recurrent

Start date: 2017-03-21
Primary completion: 2019-03-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.